German research institute BioMed X has announced a collaboration with Danish pharmaceutical giant Novo Nordisk to develop innovative oral formulation technologies for peptide drugs, including GLP-1 receptor agonists. The partnership aims to overcome critical barriers in oral peptide bioavailability through novel retention mechanisms in the lower small intestine. BioMed X, the independent biomedical research institute […]

PHC Corporation’s biomedical division has received a 2025 R&D 100 Award for LiCellMo, a live cell metabolic pathway analyser that provides continuous real-time monitoring of glucose and lactate levels in cell cultures. The device addresses critical needs in cell and gene therapy research by enabling non-invasive assessment of cellular metabolic states.

diaago has announced a strategic partnership with Peak Analysis & Automation (PAA) to enhance laboratory automation capabilities. The collaboration combines PAA’s decades of robotics expertise with diaago’s distribution network, offering research laboratories flexible automation solutions including the KX-2 Collaborative Robot for streamlined workflows and improved throughput.

Cambridge-based molecular diagnostics company Cyted Health has completed a $44 million Series B financing round to accelerate commercial expansion of its minimally invasive oesophageal cancer detection platform across the United States, following successful deployment of over 35,000 tests within the NHS.

German biomedical company ARTCLINE has closed a €5 million convertible loan financing round to complete its ongoing ReActIF-ICE clinical trial evaluating the ARTICE® extracorporeal therapy. The treatment uses allogeneic immune cells from healthy donors to support dysregulated immune systems in septic shock patients.